Genetic Susceptibility to Keloid Disease and Hypertrophic Scarring: Transforming Growth Factor β1 Common Polymorphisms and Plasma Levels
- 1 February 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 111 (2) , 535-543
- https://doi.org/10.1097/01.prs.0000041536.02524.a3
Abstract
An abstract is unavailable. This article is available as a PDF only.Keywords
This publication has 24 references indexed in Scilit:
- Hypertrophic scar tissues and fibroblasts produce more transforming growth factor‐β1 mRNA and protein than normal skin and cellsWound Repair and Regeneration, 2000
- On the Nature of Hypertrophic Scars and Keloids: A ReviewPlastic and Reconstructive Surgery, 1999
- The molecular basis of keloid and hypertrophic scar formationMolecular Medicine Today, 1998
- Increased Types I and III Collagen and Transforming Growth Factor-β1 mRNA and Protein in Hypertrophic Burn ScarJournal of Investigative Dermatology, 1995
- Transforming Growth Factor β in Tissue FibrosisNew England Journal of Medicine, 1994
- Activation of Collagen Gene Expression in Keloids: Co-Localization of Type I and VI Collagen and Transforming Growth Factor-β1 mRNAJournal of Investigative Dermatology, 1991
- Keloids: a review of the literatureBritish Journal of Plastic Surgery, 1990
- Transforming Growth Factor βAdvances in Cancer Research, 1988
- Reduced growth-factor requirement of keloid-derived fibroblasts may account for tumor growth.Proceedings of the National Academy of Sciences, 1988
- Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cellsNature, 1985